Cambridge Healthtech Institute's Third Annual

Emerging Technologies for Antibody Discovery

( 发现抗体的最新技术 )

Exploring the Intersection of Display Technologies, Next-Generation Sequencing and Informatics for the Discovery of Next-Generation Biotherapeutics

2018年1月11日 - 12日

 

As large pharma continues its integration of biologic drugs into its product portfolios and discovery operations, it is imperative that industry companies identify truly novel drug targets for unmet medical needs - and that the biotherapeutics against these are selected and engineered to minimize development risk. For 2018, Cambridge Healthtech Institute's Third Annual Emerging Technologies for Antibody Discovery meeting considers the intersection of traditional display-based screening and selection approaches with next-generation tools such as immune repertoire sequencing, in silico modeling and high resolution imaging.

We invite presentation proposals on the following preliminary topics:

  • Advances in library design
  • Emerging display technologies
  • Generating large scale libraries using CRISPR
  • High content analysis of antibody selections
  • Improving the efficiency of phage panning with deep sequencing
  • Integrated discovery platforms
  • New immunization approaches and technologies
  • NGS for difficult targets
  • Screening for activity in the final format
  • Single cell antibody cloning and sequencing
  • Structural biology in antibody discovery
  • Structure and sequence analysis for early developability analysis

* 活动内容有可能不事先告知作更动及调整。